Stephen DeFalco Joins MDS as COO; Lorah Perlee Named Director of Scientific Applications at Protedyne; Raymond Land Appointed VP and CFO of Orchid Biosciences; Mason Morfit Joins Board of Solexa; David Basiji Named CEO of Amnis; and Others

Apr 27, 2005

Stephen DeFalco has joined MDS as chief operating officer, the company said this week.

DeFalco will succeed John Rogers as president and chief executive officer of MDS. Rogers plans to retire by the end of 2005.

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.